Levetiracetam Tablet, Film Coated
Product Images NDC 71335-2098

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 71335-2098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 01)

A formula for calculating total daily dose (mL/day) of medication based on daily dose (mg/kg/day) multiplied by patient weight (kg), divided by concentration (100 mg/mL). It is a dosing calculation instruction likely related to Levetiracetam dosing.*

FDA Label Image

Figure 2 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 02)

A text panel showing formulas for calculating creatinine clearance (CLcr) based on age, weight, serum creatinine, and adjustment for body surface area (BSA), including a factor for female patients. The panel provides mathematical expressions for CLcr and its adjustment per square meter of BSA.*

FDA Label Image

Structure (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 03)

Chemical structure of the active ingredient levetiracetam, showing its molecular arrangement with a pyrrolidone ring and associated side groups.*

FDA Label Image

Figure 4 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 04)

A vertical bar chart comparing the percentage of patients across three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 3000 mg/day. The y-axis represents the percentage of patients from 0% to 45%. The placebo group shows 7.4%, Levetiracetam 1000 mg/day shows 37.1%, and Levetiracetam 3000 mg/day shows 39.6%.*

FDA Label Image

Figure 5 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 05)

A bar chart displaying the percentage of patients in three groups: Placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The percentages are approximately 6.3% for Placebo, 20.8% for Levetiracetam 1000 mg/day, and 35.2% for Levetiracetam 2000 mg/day, with an asterisk marking the latter two bars.*

FDA Label Image

Figure 6 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 06)

Bar chart comparing the percentage of patients between two groups: Placebo (N=104) at approximately 14.4%, and Levetiracetam 3000 mg/day (N=180) at approximately 39.4%. The y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 7 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 07)

A bar chart comparing the percentage of patients responding to Placebo and Levetiracetam. The y-axis represents the percentage of patients from 0% to 45%. The Placebo group (N=97) shows 19.6%, while the Levetiracetam group (N=101) shows 44.6%, with an asterisk indicating statistical significance.*

FDA Label Image

Figure 8 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 08)

Bar chart comparing the percentage of patients for two groups: Placebo (N=51) with 19.6% and Levetiracetam (N=58) with 43.1%. The y-axis is labeled '% of Patients' and ranges from 0% to 45%.*

FDA Label Image

Figure 9 (E24dd8a7 86c4 4979 8f2e Da2d82f5d6d8 09)

A bar chart comparing two groups of patients, Placebo (N=84) and Levetiracetam (N=79), showing percentage values on the vertical axis. The Levetiracetam group has a higher percentage of patients (72.2%) compared to the Placebo group (45.2%). The chart highlights a difference between these two groups in a clinical context.*

FDA Label Image

Label (Lbl713352098)

Label for Levetiracetam 750 mg tablet by Bryant Ranch Prepack, comparing to Keppra 750 mg tablet by Lupin Limited. The label indicates a package count of 30 tablets with storage instructions at 20°-25°C (68°-77°F), a lot number 1523487, and the NDC 71335-2098. It includes a barcode and a warning to keep drugs out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.